Prevalence and Severity of Depression Among People Living with Human Immunodeficiency Virus in Yenagoa, Southern Nigeria (original) (raw)

Abstract

Background: Depression is a mental health condition that affects approximately 350 million people worldwide. People living with HIV and AIDS (PLWHA) are at increased risk of developing this condition. Identification of location-specific factors is crucial to minimizing this presentation in this sub-population. Aim: The aim of this study was to measure the prevalence, severity, and associated sociodemographic and comorbidity of depression among people living with HIV and AIDS in a laboratory setting in Yenagoa, southern Nigeria. Methods: This is a cross-sectional study carried out on 282 PLWHA, aged 18 years and over. They receive HIV screening services in the laboratory of the Federal Medical Center, Yenagoa from March to April 2017. Sociodemographic data of respondents and selected comorbidities were collected using a modified structured questionnaire from the World Health Organization STEPS tool. Retrieving CD4+ count results from the laboratory registry, and height, weight, and body mass index (BMI) were measured. The presence of depression was assessed using the Patients Health Questionnaire-9 tool and performed a multivariate logistic regression analysis to identify factors associated with depression with a 95% confidence level. Results: The mean age of the respondents was 40±8.8 years and most of them were females 195 (69.2%). Seventy-five (26.6%) of the respondents were depressed, of whom 10 (13.3%) had severe depression, while 41 (54.7%) had mild depression. The most common symptoms of depression were fatigue (30.1%) and dysphoria (28.7%). There was an association between depression and CD4+ count <350 cells/µL with an adjusted odds ratio (aOR) of 2.04 (95% CI: 1.14-3.63) and underweight with an aOR of 2.56 (95%CI: 1.01-6.47), while HAART with an aOR of 0.38 (95% CI: 0.18-0.84) was associated with decreased odds of developing depression. Conclusion: Depression appeared among a significant proportion of people living with HIV and AIDS in Yenagoa, southern Nigeria, and fatigue was the most common symptom of depression. Lack of HAART, low CD4+ count, and being underweight appear to be the major factors negatively associated with depression. There is therefore a need to ensure people living with HIV and AIDS continue to receive HAART to improve CD4+ count and increase BMI.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (25)

  1. Shittu RO, Issa BA, Olanrewaju GT, et al. Prevalence and correlates of depressive disorders among people living with HIV/AIDS in North-Central Nigeria. J AIDS Clin Res 2013; 4(11):251. https://doi.org/10.4172/2155-6113.1000251
  2. Rabkin J. Depression and HIV. Focus (San Francisco, California) 2004; 19(10):1-5. https://doi.org/10.1016/0022-510x(92)90235-d
  3. Marcus M, Yasamy MT, van Ommeren M, Chisholm D. Depression, A global public health concern. WHO Department of Mental Health and Substance Abuse. 2012:18.
  4. Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLOS MED 2006: 3(11): e442. https://doi.org/10.1371/journal.pmed.0030442
  5. Marinho M, Mota-Oliveira M, Peixoto MJ, Marques J, Braganca M. Depression among HIV-infected patients-a reality that must not be forgotten. Euro Psych 2016; 33: S526. https://doi.org/10.1016/j.eurpsy.2016.01.1948
  6. Chikezie UE, Otakpor AN, Kuteyi OB, James BO. Depression among people living with human immune- deficiency virus infection/acquired immunodeficiency syndrome in Benin City, Nigeria: A comparative study. Niger J Clin Pract 2013; 16(2): 238-242. https://doi.org/10.4103/1119-3077.110148
  7. Kinyanda E, Hoskins S, Nakku J, Nawaz S, Patel V. The prevalence and characteristics of suicidality in HIV/AIDS as seen in an African population in Entebbe district, Uganda. BMC Psychiat 2012; 12: 63. https://doi.org/10.1186/1471-244x-12-63
  8. Abas M, Ali GC, Nakimuli-Mpungu E, Chibanda D. Depression in people living with HIV in sub-Saharan Africa: time to act. Trop Med Int Health 2014; 19: 1392-96. https://doi.org/101111/tmi.12382
  9. Tsao JC, Dobalian A, Moreau C, Dobalian K. Stability of anxiety and depression in a national sample of adults with human immunodeficiency virus. J Nerv Ment Dis 2004; 192(2): 111-18. https://doi.org/10.1097/01.nmd.0000110282.61088.cc
  10. Song JY, Lee JS, Seo YB, Kim IS, Noh JY, Baek JH, et al. Depression among HIV-infected patients in Korea: Assessment of clinical significance and risk factors. Infect Chemother 2013; 45(2):211-6. https://doi.org/10.3947/ic.2013.45.2.2110
  11. Obadeji AO, Ogunlesi AO, Adebowale T. Prevalence and Predictors of Depression in People living with HIV/AIDS Attending an Outpatient Clinic in Nigeria. Iran J Psychiat Behav Sci 2014; 8(1): 26-31. PMID: 24995027
  12. Ngum PA, Fon PN, Ngu RC, Verla VS, Luma HN. Depression among HIV/AIDS Patients on Highly Active Antiretroviral Therapy in the Southwest Regional Hospitals of Cameroon: A Cross-Sectional Study. Neurol Ther 2017; 6(1): 103-114. https://doi.org/10.1007/s40120-017-0065-9
  13. Amiya RM, Poudel KC, Poudel-Tandukar K, Kobayashi J, Jimba M. Antiretroviral therapy as a risk factor for depression, suicidal ideation, and suicide attempts among people living with HIV/AIDS in the Kathmandu Valley, Nepal. Sex Trans Infect 2013; 89. https://doi.org/101136sextrans-2013-051184.1044
  14. Duko B, Geja E, Zewude M, Mekonen S. Prevalence and associated factors of depression among patients with HIV/AIDS in Hawassa, Ethiopia, cross-sectional study. Ann Gen Psychiatry 2018; 17(1). https://doi.org/10.1186/s12991-018-0215-1
  15. Shukla M, Agarwal M, Singh JV, et al. Predictors of depression among people living with HIV/AIDS on antiretroviral therapy attending tertiary care hospitals in the capital of Uttar Pradesh : A cross-sectional study. Indian J Soc Psychiat 2017; 33:159-64. https://doi.org/10.4103/0971-9962.209200
  16. Manoel L, Onofre A, Filho B, et al. Depressive Symptoms and Associated Factors among People Living with HIV/ AIDS. J Int Assoc Provid AIDS Care 2015; 14(2):136-40. https://doi.org/10.1177/2325957413494829
  17. Reis RK, Melo ES, Castrighini CDC, et al. Prevalence and factors associated with depressive symptoms in individuals living with HIV/AIDS. Salud Mental 2017; 40(2):57-62. https://doi.org/10.17711/SM.0185-3325.2017.008
  18. Berhe H, and Bayray A, Prevalence of Depression and Associated Factors among People Living with HIV/AIDS in Tigray, North Ethiopia: A Cross-Sectional Hospital-Based Study. Int J Pharm Sci Res 2013; 4(2):765-75. http://www.ijpsr.com
  19. Bernard C, Dabis F, de Rekeneire N, Prevalence and factors associated with depression in people living with HIV in sub- Saharan Africa: A systematic review and meta-analysis. PLOS One 2017; 12(8):1-22. https://doi.org/10.1371/journal.pone.0181960 Editor
  20. Elbadawi A, and Mirghani H. Depression among HIV/AIDS Sudanese patients: a cross-sectional analytic study. Pan Afr Medl J 2017; 26:43. https://doi.org/10.11604/pamj.2017.26.43.10919
  21. Walsh ASJ, Wesley KL, Tan SY, Lynn C, O'Leary K, Wang Y. Screening for depression among youth with HIV in an integrated care setting. AIDS Care 2017; 29(7): 851-7. https://doi.org/10.1080/09540121.2017.1281878
  22. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16(9): 606-13. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
  23. Seid S, Abdu O, Mitiku M, Tamirat KS. Prevalence of depression and associated factors among HIV/AIDS patients attending antiretroviral therapy clinic at Dessie referral hospital, South Wollo, Ethiopia. Int J Ment Health Syst2020; 14(1). https://doi.org/10.1186.s13033-020-00389-0
  24. Parikh S, Parker C, Cooke R, Krugar S, McIntyre R, Kusznir A, et al. Bipolar Disorder : An Information Guide. Vol. Revised ed. 2015. http://www.camh.ca
  25. Yazdanpanah A, Amiri A, Jeihooni AK. The relation between general health and organizational performance in personnel of Shiraz city emergency in 2017. Universal J Pharm Res 2018; 3(1): 25-29. http://doi.org/10.22270/ujpr.v3i1.R5